Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder
2019
ABSTRACTIntroduction: Approximately 50% of adults with major depressive disorder (MDD) who receive a first-line antidepressant treatment, at an appropriate dose, do not achieve an adequate response...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
4
Citations
NaN
KQI